Vida Ventures Advisors, LLC
- SEC CIK
- 0001831423
- Latest filing
- Nov 3, 2025
DYN holding history
Dyne Therapeutics, Inc. in every 13F filed by Vida Ventures Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DYN overviewAll 13F holders of DYNFull Q3 2025 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −407,499−100.0% | Sold out | Holders |
| Q4 2024 | 407,499 | $9.60M | 6.6% | 00.0% | Unchanged | Holders |
| Q3 2024 | 407,499 | $14.6M | 10.6% | 00.0% | Unchanged | Holders |
| Q2 2024 | 407,499 | $14.4M | 15.7% | 00.0% | Unchanged | Holders |
| Q1 2024 | 407,499 | $11.6M | 6.4% | −1,667,288−80.4% | Reduced | Holders |
| Q4 2023 | 2,074,787 | $27.6M | 32.9% | −145,247−6.5% | Reduced | Holders |
| Q3 2023 | 2,220,034 | $19.9M | 30.8% | 00.0% | Unchanged | Holders |
| Q2 2023 | 2,220,034 | $25.0M | 32.6% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,220,034 | $25.6M | 35.0% | 00.0% | Unchanged | Holders |
| Q4 2022 | 2,220,034 | $25.7M | 34.6% | 00.0% | Unchanged | Holders |
| Q3 2022 | 2,220,034 | $28.2M | 25.3% | −740,012−25.0% | Reduced | Holders |
| Q2 2022 | 2,960,046 | $20.3M | 17.2% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,960,046 | $28.5M | 16.6% | 00.0% | Unchanged | Holders |
| Q4 2021 | 2,960,046 | $35.2M | 13.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 2,960,046 | $48.1M | 13.8% | 00.0% | Unchanged | Holders |
| Q2 2021 | 2,960,046 | $62.3M | 15.6% | 00.0% | Unchanged | Holders |
| Q1 2021 | 2,960,046 | $46.0M | 11.6% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.